APA (7th ed.) Citation

Y, W., X, Y., L, C., X, L., L, L., L, Y., . . . Y, L. (2026). Validation of risk stratification and novel prognostic biomarkers in asian adult HSCT recipients with TA-TMA: A multicenter real-world study. Bone marrow transplantation, 61(4), 408. https://doi.org/10.1038/s41409-025-02777-x

Chicago Style (17th ed.) Citation

Y, Wu, et al. "Validation of Risk Stratification and Novel Prognostic Biomarkers in Asian Adult HSCT Recipients with TA-TMA: A Multicenter Real-world Study." Bone Marrow Transplantation 61, no. 4 (2026): 408. https://doi.org/10.1038/s41409-025-02777-x.

MLA (9th ed.) Citation

Y, Wu, et al. "Validation of Risk Stratification and Novel Prognostic Biomarkers in Asian Adult HSCT Recipients with TA-TMA: A Multicenter Real-world Study." Bone Marrow Transplantation, vol. 61, no. 4, 2026, p. 408, https://doi.org/10.1038/s41409-025-02777-x.